Prof. Xiansheng Liu | Charismatic Leadership | Best Scholar Award

Prof. Xiansheng Liu , Charismatic Leadership, Best Scholar Award

Prof. Xiansheng Liu, Shanxi Bethune Hospital China

🔗 Professional Profiles

Summary 🌟

Dr. Liu Xiansheng is a distinguished professor and chief physician with a notable career in respiratory medicine. Currently serving as the President and Deputy Secretary of Shanxi Bethune Hospital, he has significantly contributed to the field through both his clinical practice and research. He has published over 120 papers and led numerous significant research projects, earning prestigious awards for his scientific achievements.

Education 🎓

  • Ph.D. in Respiratory Medicine
    Tongji Medical College, Huazhong University of Science and Technology (09/1999 – 07/2002)
  • Master’s in Respiratory Medicine
    Original Tongji Medical University (09/1995 – 07/1998)
  • Bachelor’s in Clinical Medicine
    Original Tongji Medical University (09/1987 – 07/1992)

Professional Experience 💼

  • President and Deputy Secretary
    Shanxi Bethune Hospital (01/2019 – Present)
  • Professor / Chief Physician
    Tongji Hospital, Huazhong University of Science and Technology (06/2002 – Present)
  • Postdoctoral Fellow
    Virginia Commonwealth University School of Medicine, USA (06/2005 – 12/2006)
  • Resident Physician
    Tongji Hospital, Huazhong University of Science and Technology (09/1992 – 07/1995)

Research Interests 🔬

Dr. Liu specializes in both basic and clinical research related to asthma and chronic obstructive pulmonary disease (COPD). His work has led to several advancements in these fields, supported by various high-profile grants and projects. His research contributions have been recognized with multiple awards, including national and provincial prizes for science and technology progress.

Publication Top Noted

Exosome microRNA-125a-5p derived from epithelium promotes M1 macrophage polarization by targeting IL1RN in chronic obstructive pulmonary disease

    • Authors: Wang, R., Zhu, Z., Peng, S., Wei, S., Liu, X.
    • Journal: International Immunopharmacology
    • Year: 2024
    • Volume: 137
    • Issue: –
    • Pages: 112466

COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms

    • Authors: Bai, X., Niu, Y., Wei, S., Liu, X., Wang, R.
    • Journal: Clinical Respiratory Journal
    • Year: 2024
    • Volume: 18
    • Issue: 6
    • Pages: e13790

Secular trends of asthma mortality in China and the United States from 1990 to 2019

    • Authors: Li, X., Guo, M., Niu, Y., Xie, M., Liu, X.
    • Journal: Chinese Medical Journal
    • Year: 2024
    • Volume: 137
    • Issue: 3
    • Pages: 273-282

Identification of novel biomarkers related to neutrophilic inflammation in COPD

    • Authors: Huang, Y., Niu, Y., Wang, X., He, Y., Liu, X.
    • Journal: Frontiers in Immunology
    • Year: 2024
    • Volume: 15
    • Issue: –
    • Pages: 1410158

Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

    • Authors: Peng, S., Tan, C., Du, L., Liu, X., Wang, R.
    • Journal: BMC Pulmonary Medicine
    • Year: 2023
    • Volume: 23
    • Issue: 1
    • Pages: 304
  •  

Soumyananda Chakraborti-Visionary Leadership Award-Best Researcher Award

Dr.  Soumyananda Chakraborti-Visionary Leadership Award-Best Researcher Award

ICMR-National Institute of Malaria Research-India

Author Profile

Early Academic Pursuits

Dr. Soumyananda Chakraborti embarked on his academic journey with a strong foundation in the sciences. He pursued a Bachelor of Science with Honors in Chemistry from the University of Calcutta, followed by a Master's degree in Biochemistry from the same institution. These formative years laid the groundwork for his future endeavors in the field of biochemistry and molecular biology.

Professional Endeavors

After completing his master's degree, Dr. Chakraborti delved into research and gained valuable experience as a Research Assistant at the Chemistry Department of the Indian Institute of Science, Bangalore. Subsequently, he served as a Research Engineer in the Biochemistry Department at Delhi University. These roles allowed him to hone his skills in experimental techniques and scientific inquiry.

His academic journey continued with a significant milestone when he pursued a Ph.D. in Biochemistry from Bose Institute, affiliated with the University of Calcutta, India. His doctoral research focused on investigating the impact of ZnO nanoparticles on proteins and cells, as well as studying the recognition of curcumin by tubulin. This research laid the foundation for his expertise in nanobiotechnology, structural biology, and bio-nanotechnology.

Contributions and Research Focus

Dr. Chakraborti's research contributions span a wide array of topics within the realm of biochemistry, molecular biology, and nanotechnology. His postdoctoral stints at prestigious institutions such as Indiana University and Institute Curie in Paris further enriched his scientific acumen.

One of his primary research focuses has been on infectious disease biology, particularly malaria, where he has made significant contributions to understanding drug resistance mechanisms and developing novel antimalarial strategies. His work on targeting prolyl-tRNA synthetase for antimalarial development stands out as a groundbreaking contribution.

Additionally, his research interests extend to structural parasitology, mosquito omics, synthetic biology, computational biology, and disease epidemiology. This multidisciplinary approach underscores his versatility and depth as a scientist.

Accolades and Recognition

Dr. Chakraborti's scholarly achievements have garnered recognition and accolades within the scientific community. With over 56 publications in reputable journals and an impressive average impact factor, his research has made a substantial impact in the field. His h-index, both on Google Scholar and Scopus, reflects the influence and significance of his contributions.

His work has been published in esteemed journals such as iScience, International Journal of Biological Macromolecules, Gene Expression, and Journal of Global Antimicrobial Resistance, among others. These publications highlight the breadth and depth of his research endeavors.

Impact and Influence on Visionary Leadership Award

Dr. Chakraborti's research has not only advanced scientific knowledge but also has practical implications in combating infectious diseases, understanding molecular mechanisms, and developing therapeutic interventions. His investigations into antimalarial drug development, protein interactions, and nano-bio interactions have the potential to reshape strategies in disease management and drug design.

His collaborations with international research groups and institutions underscore the global impact of his work and the recognition he has garnered on an international scale. His research findings have contributed to shaping the scientific discourse and have opened avenues for further exploration and innovation in related fields.

The Visionary Leadership Award celebrates individuals who embody a spirit of transformation, pushing boundaries, and driving progress through visionary initiatives. Whether in business, academia, philanthropy, or public service, recipients of this award are visionaries who inspire others to think boldly, embrace innovation, and work towards a brighter future. Their visionary leadership leaves a lasting impact, influencing trends, fostering collaboration, and leaving a legacy of positive change for generations to come.

Legacy and Future Contributions

As a Ramalingaswami Fellow and Scientist-D at the National Institute of Malaria Research in New Delhi, India, Dr. Chakraborti continues to lead groundbreaking research initiatives. His legacy is characterized by a relentless pursuit of scientific excellence, innovation, and a commitment to addressing critical challenges in infectious disease biology and drug development.

Looking ahead, Dr. Chakraborti's future contributions are poised to make significant strides in understanding complex biological processes, unraveling disease mechanisms, and translating research findings into tangible solutions for global health challenges. His multidisciplinary approach, coupled with a passion for discovery, ensures that his legacy as a visionary scientist continues to inspire generations of researchers.

The Visionary Leadership Award recognizes individuals who have demonstrated exceptional foresight, innovation, and strategic thinking in their respective fields. Recipients of this prestigious award are visionary leaders who have not only achieved remarkable success but have also paved the way for future advancements and positive change. Their ability to envision possibilities, inspire others, and navigate challenges with resilience and creativity sets them apart as exemplary leaders who shape the course of their industries and communities.

Notable publications

 

 

Hasim Ali Khan-Innovative Leadership -Editorial Board Member 

Hasim Ali Khan-Innovative Leadership -Editorial Board Member 

G. H. Raisoni College of Engineering,-India 

Author Profile 

Early Academic Pursuits

Dr. Hasim Ali Khan embarked on his academic journey at Haldia Institute of Technology, completing his B-Tech in Civil Engineering from 2009 to 2013. He further pursued his education at the National Institute of Technology Durgapur, obtaining an M-Tech in Civil Engineering from 2014 to 2016. His dedication to academic excellence laid the foundation for his subsequent impactful contributions to the field.

Professional Endeavors

Dr. Khan has been actively involved in academia and research. He served as a PhD Research Scholar in Civil Engineering at the National Institute of Technology Durgapur from July 2016 to May 2021. Currently, he holds the position of Assistant Professor in Civil Engineering at G H Raisoni College of Engineering, Nagpur, Maharashtra, since May 2021.

Contributions and Research Focus

Dr. Hasim Ali Khan has significantly contributed to the field of Civil Engineering through his research works. His diverse research topics include the use of shape memory alloy reinforcement for strengthening RCC structures, the impacts of fiber and waste material on sustainable concrete, and the experimental study on tensile and flexural strength of concrete using sugarcane bagasse ash and steel fiber. His contributions extend to numerical studies, book chapters, and comprehensive reviews.

Accolades and Recognition

Dr. Khan's research has been published in reputable journals such as Materials Today: Proceedings and Construction and Building Materials. His contributions have been acknowledged through peer reviews for various publications and grants. His commitment to quality research is reflected in the recognition he has received within the academic community.

Impact and Influence

Dr. Hasim Ali Khan's work, particularly in the areas of concrete strengthening, geosynthetic applications, and seismic retrofitting, has contributed to the advancement of knowledge in Civil Engineering. His research has practical implications for the construction industry, providing insights into sustainable and resilient building practices.

Legacy and Future Contributions

Dr. Khan's legacy lies in his commitment to advancing knowledge in Civil Engineering through research and education. His future contributions are anticipated to further enrich the understanding of structural engineering, materials, and construction practices.

Notable Publications 

 

Cem çalışkan çalışkan -Innovative Leadership-Innovation in Industry Leadership Award 

Cem çalışkan çalışkan -Innovative Leadership-Innovation in Industry Leadership Award 

World Medicine-Turkey 

Author Profile 

Early Academic Pursuits

Cem Çalışkan embarked on his academic journey with a Bachelor of Science in Chemistry from Uludağ Üniversitesi in 2003-2009. He further pursued a Master of Science (M.Sc.) in Organic Chemistry at Sakarya Üniversitesi from 2014 to 2016. Cem's academic pursuits reached their pinnacle with a Doctor of Philosophy (Ph.D.) in Analytical Chemistry from Yıldız Teknik Üniversitesi, completed between 2018 and 2022.

Professional Endeavors

With a solid educational background, Cem Çalışkan delved into the pharmaceutical industry. His professional journey includes roles such as Intern at NERGIS TEKSTİL HOLDİNG A.Ş., where he met analytical needs for textile manufacturing. Subsequently, he joined Neutec İlac as a Process Development Analyst, conducting formulation and process development studies. His role expanded as he became an R&D Analytical Development Responsible Specialist at World Medicine, overseeing analytical method development, validation, and documentation for various pharmaceutical products. Cem progressed to the position of R&D Manager at World Medicine, where he has been serving since August 2020.

Contributions and Research Focus

Cem Çalışkan's contributions in the pharmaceutical industry revolve around analytical method development, validation, and formulation process improvement. His research has led to publications addressing topics such as the determination of simethicone in drug formulations, novel HPLC methods for polyvinyl alcohol assay, and in-vitro release studies of pharmaceutical compounds. His expertise includes spectroscopy, analytical skills, and adherence to Good Laboratory Practice (GLP).

Accolades and Recognition

While specific accolades and recognition details are not provided, Cem Çalışkan's progression from an Analytical Development Responsible Specialist to the R&D Manager role suggests acknowledgment and appreciation for his contributions within the pharmaceutical industry.

Impact and Influence

Cem Çalışkan's impact is evident in his role as R&D Manager, where he oversees analytical development and contributes to the advancement of pharmaceutical products. His involvement in analytical method development and validation demonstrates a commitment to ensuring the quality and safety of pharmaceutical formulations.

Legacy and Future Contributions

Cem Çalışkan's legacy lies in his multifaceted contributions to pharmaceutical R&D, from analytical method development to formulation improvement. His future contributions are likely to involve continued advancements in pharmaceutical research, emphasizing innovation and ensuring the highest standards of quality in drug development. As an experienced R&D Manager, he is poised to leave a lasting impact on the pharmaceutical industry.

Notable Publications